HIV Drug Maraviroc Effective For Drug-Resistant Patients
Oct 3rd 2008Drug InformationClinical Trials
As many as one quarter of HIV patients have drug resistance, limiting their treatment options and raising their risk for AIDS and death. Now, maraviroc, the first of a new class of HIV drugs called CCR5 receptor antagonists, has been shown to be effective over 48 weeks for drug-resistant patients with R5 HIV-1, a variation of the virus found in more than half of HIV-infected patients.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
